R&D Centre

The MEDISEPT R&D Centre is a modern facility,

equipped with state-of-the-art research equipment and staffed by highly experienced specialists.

The Centre is currently conducting work on the Research Agenda. The project is entitled: "Development of innovative disinfectant formulations with a maximally reduced amount of active substances (compared with products currently available on the market), also effective against bacterial biofilms of antibiotic-resistant strains."

The complex, located next to the company’s headquarters in a Special Economic Zone, brings together leading experts in the field.
The MEDISEPT R&D Centre comprises, among others a Virology Laboratory, a Microbiology Laboratory, and a Cell Culture Laboratory. Its mission is to support the company in developing increasingly effective products. The facility enables performance testing, stability studies, and the implementation of innovations, while also offering commercial laboratory services.

CELL CULTURE
LABORATORY (BIOSAFETY LEVEL 2)

VIROLOGY LABORATORY (BIOSAFETY LEVEL 2)

MICROBIOLOGY LABORATORY (BIOSAFETY LEVEL 2)

Laboratorium fizykochemiczne

CELL CULTURELABORATORY
(BIOSAFETY LEVEL 2)

In our BSL-2 in vitro cell culture laboratory, we work with a variety of cell lines. At present, we maintain mammalian cell lines (Vero, RAW), including human cell line (HeLa). Vero cells were isolated from epithelial tissue of the kidney of the African green monkey. RAW cells are derived from a mouse tumour. HeLa cells represent the first immortalised human cell line, originally derived from cervical cancer cells.

VIROLOGY
LABORATORY
(BIOSAFETY LEVEL 2)

In our BSL-2 Virology Laboratory, we conduct studies on the virucidal efficacy of disinfectants in accordance with EN 14885, which specifies the evaluation of chemical disinfectants and antiseptics. We perform efficacy testing of products against enveloped viruses (Vaccinia virus) as well as limited virucidal activity using the test models: Adenovirus and Murine Norovirus. In addition, we carry out studies on disinfectants used in the veterinary field, applying Bovine Enterovirus (ECBO).

All virological studies are performed in compliance with:

PN-EN 14476:2013+A2:2019

Quantitative suspension test for the evaluation of virucidal activity in the medical area

(Phase 2/Step 1)

EN 17111:2018

Chemical disinfectants and antiseptics — Quantitative carrier test method for the evaluation of virucidal activity on instruments used in the medical area

(Phase 2, Step 2)

EN 16777:2018

Chemical disinfectants and antiseptics — Quantitative non-porous surface test without mechanical action for the evaluation of virucidal activity of chemical disinfectants used in the medical area

(Phase 2, Step 2)

PN-EN 14675:2015-06

Quantitative suspension test for the evaluation of virucidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2/Step 1)

PN-EN 17122:2020-04

Chemical disinfectants and antiseptics — Quantitative non-porous surface test for the evaluation of virucidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2, Step 2)

MICROBIOLOGY
LABORATORY
(BIOSAFETY LEVEL 2)

In our BSL-2 Microbiology Laboratory, we conduct studies on the bactericidal and fungicidal efficacy of disinfectants in accordance with EN 14885, which specifies the evaluation of chemical disinfectants and antiseptics. These studies are carried out using reference strains of bacteria and fungi obtained from the American Type Culture Collection (ATCC).

The microbiological tests are performed in compliance with:

PN-EN 13624:2022-04

Quantitative suspension test for fungicidal or yeasticidal activity in the medical area

(Phase 2/Step 1)

PN-EN 13727+A2:2015-12

Quantitative suspension test for bactericidal activity in the medical area

(Phase 2/Step 1)

PN-EN 13697+A1:2019-08

Quantitative non-porous surface test for bactericidal and fungicidal activity in food, industrial, domestic and institutional areas

(Phase 2, Step 2)

PN-EN 1656:2020-01

Chemical disinfectants and antiseptics — Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2/Step 1)

PN-EN 1657:2016-06

Chemical disinfectants and antiseptics — Quantitative suspension test for the evaluation of fungicidal or yeasticidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2/Step 1)

PN-EN 14349:2013-05

Chemical disinfectants and antiseptics — Quantitative non-porous surface test without mechanical action for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2, Step 2)

PN-EN 16438:2014-04

Chemical disinfectants and antiseptics — Quantitative non-porous surface test without mechanical action for the evaluation of fungicidal or yeasticidal activity of chemical disinfectants and antiseptics used in the veterinary field

(Phase 2, Step 2)

BIOCIDAL PRODUCT TESTING

Veterinary Area

EN 14675

Suspension test: viruses (Phase 2/Step 1) incl. virucidal activity against ASFV

EN 17122

Surface test: viruses (Phase 2/Step 2)

EN 1656

Suspension test: bacteria (Phase 2/Step 1)

EN 1657

Suspension test: fungi (Phase 2/Step 1)

EN 14349

Surface test: bacteria (Phase 2/Step 2)

EN 16438

Surface test: fungi (Phase 2/Step 2)

EN 16437

Porous surface test: bacteria (Phase 2/Step 2)

Medical Area

EN 14476

Suspension test: viruses (Phase 2/Step 1)

EN 16777

Surface test: viruses (Phase 2/Step 2)

EN 17111

Instrument test: viruses (Phase 2/Step 2)

EN 13727

Suspension test: bacteria (Phase 2/Step 1)

EN 13624

Suspension test: fungi (Phase 2/Step 1)

EN 17387

Surface test: bacteria and fungi (Phase 2/Step 2)

EN 14561

Instrument test: bacteria (Phase 2/Step 2)

EN 14562

Instrument test: fungi (Phase 2/Step 2)

EN 16615

4-field test: bacteria and yeasts (Phase 2/Step 2)

Food & General Area

EN 13697

Surface test: bacteria and fungi (Phase 2/Step 2)

EN 1276

Suspension test: bacteria (Phase 2/Step 1)

EN 1650

Suspension test: fungi (Phase 2/Step 1)

EN 13623*

Biocidal activity – Legionella (Phase 2, Step 1)

Other

EN 17272

Room fogging – viruses, bacteria, fungi (Dry Disinfection testing)

* Methods performed by subcontractors.

Certyfikat ISO 17025 Medisept

download

Accreditation scope: AB 1918

About the R&D Centre

Fill in the form or write to us at:
cbr@medisept.pl

Name *

Phone *

E-mail *

Choose message subject *

City *

Message *

I consent to the processing of my personal data by the Data Controller: MEDISEPT sp. z o.o. with its registered office in Lublin, NIP (Tax Identification Number): 946-00-10-016, for the purposes of direct marketing of the Controller’s goods and services. Providing the data is voluntary but necessary to enable communication via email and/or telephone.

INFORMATION CLAUSE
The controller of personal data is MEDISEPT sp. z o.o. with its registered office in Lublin, at ul. Spiessa 4, 20-270 Lublin, NIP (Tax Identification Number) 946-00-10-016, phone number +48 81 535 22 30 (hereinafter: the “Controller” or the “Company”).
Personal data will be processed by the Company on the basis of the legitimate interests of the controller for the purposes of direct marketing of the Controller’s goods and services, which include: conducting dialogue, presenting and selling its products and services, as well as establishing contact with customers, and providing them with information about MEDISEPT, its new products and services, by email or by telephone. The legal basis for processing is Article 6(1)(f) of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (GDPR).

Personal data are provided directly by the data subject.

Personal data may be disclosed to employees and/or associates of the Company who are obliged to comply with applicable law, as well as to entities cooperating with the Company on the basis of commissioned services. Such entities process data as subcontractors, solely under a data processing agreement and/or data sharing agreement concluded with the Company, and only in accordance with its instructions. These entities include, in particular: IT service providers, courier, transport, postal and legal service providers. In addition, data may be disclosed to entities authorised under applicable law.

Personal data will be processed under the Controller’s legitimate interest for the period necessary to conduct correspondence and achieve the purpose for which it was collected, and subsequently – for the time necessary to secure any possible claims, or for the period required by law (e.g. tax regulations).

The processing of personal data does not involve automated decision-making or profiling. Each data subject has the right to: (i) access their data and rectify it, (ii) request its erasure, (iii) request restriction of processing, (iv) request data portability.

To exercise these rights, please contact the Controller in writing at the registered office of MEDISEPT sp. z o.o. (with the note "GDPR") or electronically via the email address: rodo@medisept.pl.

The data subject has the right to lodge a complaint with the President of the Personal Data Protection Office (PUODO) if they consider that the processing of their personal data infringes the provisions of the GDPR. Providing personal data is voluntary; however, it is necessary to enable communication via email and/or telephone. Detailed information regarding the principles of personal data processing can be found here.

* - required field